Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02535806
Title Four Drug Reinduction With Bortezomib for Relapsed or Refractory ALL or LL in Children and Young Adults
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Children's Mercy Hospital Kansas City
Indications

acute lymphoblastic leukemia

lymphoid leukemia

B-cell acute lymphoblastic leukemia

T-cell lymphoblastic leukemia/lymphoma

Therapies

Vincristine Sulfate

Bortezomib

Pegaspargase

Methotrexate

Cytarabine

Mitoxantrone

Prednisone

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.